Milestone Pharmaceuticals (MIST) Earnings Date & Reports

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

MIST is expected to report earnings to fall 42.74% to -17 cents per share on August 06

Milestone Pharmaceuticals MIST Stock Earnings Reports

Q2'25

Est.

$-0.18

Q1'25

Missed

by $0.11

Q4'24

Missed

by $0.03

Q3'24

Beat

by $0.02

Q2'24

Beat

by $0.05

The last earnings report on May 14 showed earnings per share of -31 cents, missing the estimate of -20 cents. With 1.09M shares outstanding, the current market capitalization sits at 99.44M.

View a ticker or compare two or three

Compare

MIST